XLO - Xilio Therapeutics Forvard P/S multiplikatori

Xilio (XLO) korporativ emblemasi va logotipi

Xilio Therapeutics, Inc. (XLO) kompaniyasining prognoz qilingan P/S ko'rsatkichi valyuta omillarining biznes baholashiga ta'sirini vizuallashtiradi, 1.00 esa ushbu metrikaning joriy qiymatini ko'rsatadi. Xilio Therapeutics, Inc. (XLO) o'simtalarda faollashadigan ilg'or sitokinlarni ishlab chiqmoqda. Brendning ilmiy nufuzi aniq immuno-onkologik agentlarning yaratilishiga asoslangan. Operatsion model ishlab chiqarish va barcha klinik sinovlarni o'tkazishda tashqi pudratchilarga tayanadi.

XLO Xilio: Bozor kapitallashuvining kelajakdagi daromadga nisbati 10.08.2024 - 16.11.2026 oraligʻida

Xilio Therapeutics (XLO) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning jamlanma tahlili:Xilio XLO
xiliotx.com tomonidan chiqariladigan mahsulotlar

Xilio Therapeutics, Inc. (XLO) kompaniyasining bozor pasayishlariga chidamliligini baholash ishlab chiqarishni CDMO ob'ektlariga autsorsing qilish orqali xarajatlarni optimallashtirishga tayanadi, bu esa kapital risklarini minimallashtiradi. Bashorat qilingan P/S koeffitsiyentini tahlil qilish orqali investor onkobiotexnologiya sohasidagi kelajakdagi muvaffaqiyatlar uchun to'langan premiumni aniqlash va biznesning baholanishiga tegishli bozor konsensusining adolatli ekanligini baholash uchun joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan solishtiradi.

Raqobatchilar tahlili

Forvard P/S multiplikatori ONC (BeiGene Oncology)|Forvard P/S multiplikatori Halozyme Corp HALO|RVMD: Forvard narx/daromad multiplikatori|Ascentage Pharma Group (AAPG) - Forvard narx/daromad multiplikatori|CG Oncology Therapeutics (CGON) - Narxning prognoz qilingan daromadga nisbati|Prognoz narxning daromadga nisbati UroGen Pharma URGN|Narxning prognoz qilingan daromadga nisbati Bicara Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Personalis Genomics PSNL|Forvard P/S multiplikatori ERAS|Narxning kutilayotgan daromadga nisbati DCTH|Y-mAbs Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aura Biosciences Inc (AURA)|CADL: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ARAY (Accuray Inc.)|SLS: Forvard P/S multiplikatori|ACTU: Narxning kutilayotgan daromadga nisbati|CTOR (Citius Oncology Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati tuhurabio.com HURA|Forvard P/S multiplikatori TARA|FATE: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori WHWK (Aadi Bioscience)|TCRX (TScan) - Kelajakdagi narxning daromadga nisbati|Champions Oncology, Inc. - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati XBiotech Inc XBIT|CVM: Forvard P/S multiplikatori|OSTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Radiopharm Theranostics Limited|Forvard P/S multiplikatori artivabio.com|Forvard narx/daromad multiplikatori ANL (Adlai Nortye Limited)|Veru - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Tempest Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Enochian BioSciences - Narxning prognoz qilingan daromadga nisbati|Mural Oncology - Forvard P/S multiplikatori|KAPA - Forvard P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori CytoMed|Narxning prognoz qilingan daromadga nisbati curis.com|Forvard narx/daromad multiplikatori Apollomics, Inc. (APLM)|Forvard P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Genprex GNPX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Calidi Bio (CLDI)|sunshinebiopharma.com - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati xeneticbio.com|salariuspharma.com (SLRX) - Narxning prognoz qilingan daromadga nisbati|Purple Biotech Ltd. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati AON|Forvard P/S multiplikatori BeiGene Ltd.|Narxning prognoz qilingan daromadga nisbati Checkpoint Therapeutics, Inc. (CKPT)|Forvard narx/daromad multiplikatori Elevation Oncology, Inc. ELEV|Forvard P/S multiplikatori ICAD (iCAD Inc.)|IKNA - Forvard narx/daromad multiplikatori|NTBL: Forvard narx/daromad multiplikatori|viracta.com (VIRX) - Forvard narx/daromad multiplikatori|MorphoSys (MOR) - Narxning prognoz qilingan daromadga nisbati|NAYA Biosciences Corp (NAYA) - Forvard P/S multiplikatori|AAPGV (Ascentage) - Forvard P/S multiplikatori